Overview
History
Business Strategy
Corporate Governance
Directors
Overview
Technology Platform
Pharmaceutical Drug Development
Consumer Health
Open Consumer Health Website
Overview
The Technology
Drug Development
Oncology Program
Cardiovascular Program
Dermatological Program
Anti-inflammatory Program
ASX/NASDAQ Releases
Press Releases / Current News
Boardroom Radio
Newsletter
Archive
Shares
How To Invest
Annual reports
Presentations
Analysts Reports
Offices
Investor Contacts
Media Contacts
Clinical Trials
Phone Numbers
Australia:
+612 9878 0088
Canada
+1 416 628 8086
Nederlands
+31 35 548 0548
UK
+44 17 5383 3321
Media Contacts
For more information:
australia@novogen.com
About Novogen
|
Knowledge Base
|
Consumer Health
|
Pharmaceuticals
|
News
|
Investor Relations
|
Contact
|
Site Map
Copyright © 2010 Novogen The world leader in isoflavone research - with products including
Promensil
and
Trinovin
|
Web Design by Newgency